Sampo (SAMPO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
6 May, 2026Executive summary
Strong operational momentum in Q1 2026, with robust underwriting results and top-line growth led by Nordic private and SME lines, while UK and large corporate segments were more muted.
Underwriting result grew 9% year-over-year (currency adjusted) to EUR 368 million, with operating EPS up 19% to EUR 0.13, though reported EPS fell to EUR -0.02 due to market volatility.
Insurance revenue rose 8% year-over-year to EUR 2,363 million, driven by strong gross written premium growth.
Full-year 2026 guidance for underwriting result raised to EUR 1,525–1,625 million and a new EUR 350 million share buyback program announced.
Solvency II coverage robust at 174%, with prudent reserving and financial leverage stable at 23.7%.
Financial highlights
Underwriting result increased by 9%–10% year-over-year to EUR 368 million, supported by favorable claims experience and operational momentum.
Operating EPS rose 19% year-over-year to EUR 0.13, aided by higher underwriting results and technical factors.
Insurance revenue guidance for 2026 updated to 6%–8% growth (EUR 9.6–9.8 billion); underwriting result guidance raised to 3%–9% growth (EUR 1,525–1,625 million).
Combined ratio improved to 84.4% from 84.6%; cost ratio down to 24.8%.
Net investment income declined to EUR -276 million due to market volatility and NOBA loss, despite resilient interest income.
Outlook and guidance
Full-year 2026 guidance increased for both insurance revenue and underwriting result, reflecting strong Q1 performance and favorable claims outcomes.
Combined ratio target remains below 85%; operating EPS growth target above 9% annually on average.
Committed to returning around 90% of operating results to shareholders via dividends and buybacks in a typical year.
Investor update scheduled for November 17 to outline ambitions for the next strategic period.
Latest events from Sampo
- Net profit up 73%, EPS up 65%, and dividend increased on strong insurance and NOBA gains.SAMPO
Q4 202516 Apr 2026 - Share-based offer creates a top Nordic P&C insurer with EUR 95m synergies and 27% premium.SAMPO
M&A Announcement13 Mar 2026 - H1 2025 delivered strong growth, margin gains, and a new EUR 200m share buyback program.SAMPO
Q2 20253 Feb 2026 - Strong growth, profit, and Topdanmark integration drive robust results and outlook.SAMPO
Q2 20242 Feb 2026 - Profit before taxes up 20% with strong UK/Nordic growth and Topdanmark fully integrated.SAMPO
Q3 202416 Jan 2026 - 12% growth, higher dividend, and robust underwriting drive strong 2024 performance.SAMPO
Q4 20249 Jan 2026 - Q1 2025 growth, raised outlook, higher Topdanmark synergies, and share split completed.SAMPO
Q1 202525 Nov 2025 - Premiums and profits rose, combined ratio improved, and a EUR 200m buyback was announced.SAMPO
Q2 202523 Nov 2025 - Net profit up 50%, EPS up 40%, and new buyback launched after EUR 355m IPO gain.SAMPO
Q3 20256 Nov 2025